Form 4: Xtant Medical Holdings Director Vizirgianakis Reports Acquisition of Stock Units

Director Stavros G. Vizirgianakis reports acquisition of deferred stock units in Xtant Medical Holdings, Inc. under the 2023 Equity Incentive Plan.

Summary

• On August 15, 2024, Stavros G. Vizirgianakis, a director of Xtant Medical Holdings, Inc., acquired 243,243 shares of common stock through a deferred stock unit award.
• Additionally, Mr. Vizirgianakis acquired 505,405 shares of common stock through another deferred stock unit award.
• These shares vest on August 15, 2025, contingent upon Mr. Vizirgianakis remaining a director of Xtant Medical Holdings, Inc.
• Following these transactions, Mr. Vizirgianakis beneficially owns 6,961,773 shares of Xtant Medical Holdings, Inc., including 966,418 shares issuable upon settlement of deferred stock units.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The acquisition of stock units by a director suggests confidence in the company's future, but it's a routine transaction.

Positives

• The acquisition of deferred stock units by a director signals confidence in the company's future.
• The vesting condition of continued service as a director aligns the director's interests with the long-term success of the company.

Future Outlook

The document does not contain specific forward-looking statements beyond the vesting conditions of the stock units.

Industry Context

This filing is a routine disclosure related to insider transactions and is typical for publicly traded companies. It provides transparency regarding the holdings of company insiders.

Comparison to Industry Standards

• Equity compensation is a common practice in the medical device industry to align the interests of directors and management with shareholders.
• Companies like Medtronic, Stryker, and Johnson & Johnson also utilize equity incentive plans for their executives and directors.
• The vesting conditions tied to continued service are standard practice to ensure long-term commitment.

Stakeholder Impact

• The transaction could have a minor positive impact on shareholder sentiment as it reflects insider confidence.
• Employees may view this as a positive sign of leadership commitment.

Key Dates